Post-Uterine Artery Embolization Pain and Clinical Outcomes for Symptomatic Myomas Using Gelfoam Pledgets Alone Versus Embospheres Plus Gelfoam Pledgets: A Comparative Pilot Study

Abstract Background To evaluate the efficacy and post-procedural pain associated with uterine artery embolization (UAE) using Gelfoam alone versus Embospheres plus Gelfoam in women with symptomatic uterine fibroids. Method We conducted a prospective, non-randomized pilot study. Fluoroscopy-guided tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of obstetrics and gynaecology Canada 2014-11, Vol.36 (11), p.983-989
Hauptverfasser: Vilos, Angelos G., MD, Vilos, George A., MD, Hollett-Caines, Jackie, MD, Garvin, Greg, MD, Kozak, Roman, MB BS, Abu-Rafea, Basim, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 989
container_issue 11
container_start_page 983
container_title Journal of obstetrics and gynaecology Canada
container_volume 36
creator Vilos, Angelos G., MD
Vilos, George A., MD
Hollett-Caines, Jackie, MD
Garvin, Greg, MD
Kozak, Roman, MB BS
Abu-Rafea, Basim, MD
description Abstract Background To evaluate the efficacy and post-procedural pain associated with uterine artery embolization (UAE) using Gelfoam alone versus Embospheres plus Gelfoam in women with symptomatic uterine fibroids. Method We conducted a prospective, non-randomized pilot study. Fluoroscopy-guided trans-femoral artery UAE was performed using Gelfoam pledgets alone or Embospheres (500 to 700 mg) plus Gelfoam under conscious sedation and local anaesthesia. This was followed by patient-controlled analgesia (PCA) using a morphine pump overnight. Post-procedural pain was assessed by the mean amount of self-administered morphine delivered by PCA pump (mL) from 0 to 19 hours in each group. The mean volumes of the uterus and the dominant fibroid were calculated by ultrasound at baseline, three months, six months, and 12 months. Results A total of 17 women participated in the study. Bilateral uterine artery occlusion was performed in eight women using Gelfoam alone, and in nine women using Embosphere + Gelfoam. One woman in the Embosphere + Gelfoam group developed a puncture-site hematoma requiring further intervention one week later. The mean (SD) amount of morphine self-administered by PCA pump at time 0, 1, and 2 hours was 3.4 mg (3.1), 2.9 mg (2.2), and 2.4 mg (3.3) in the Gelfoam-only group and 6.1 mg (3.0), 9.6 mg (7.1), and 5.3 mg (4.4) in the Embosphere + Gelfoam group, respectively. After three hours, the amount of morphine used was equal in both groups. The mean (SD) total dose of morphine used was 29.5 mg (18.6) in the Gelfoam group and 41.1 mg (19.3) in the Embosphere + Gelfoam group ( P = 0.228). At 12 months, the reduction in median total uterine volume and median dominant fibroid volume in each group was equal. Conclusion Clinical outcomes were equivalent after uterine artery embolization using Gelfoam alone versus Gelfoam + Embospheres. Although the amount of immediate post-procedure pain may be less with Gelfoam alone, we could not demonstrate this objectively using morphine use as a measure of pain.
doi_str_mv 10.1016/S1701-2163(15)30411-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1645779881</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1701216315304114</els_id><sourcerecordid>1645779881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-387342948a7b962c808aaf2e268d274ada3233cf8fbf5e92a25e14200f95567c3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhbMA0VJ4BJCXZRHwb5ywAI1GpSAVNdIwbC2Pc1NcnHiwnUrhtfqC9fzQRTesfHV1znd0fYriDcHvCSbVhxWRmJSUVOyciHcMc0JK_qw4fVyfFC9jvMVYSCabF8UJFULySorT4r71MZXrBMGOgBYhDzO6GDbe2b86WT-iVtsR6bFDS2dHa7RD11MyfoCIeh_Qah62yQ9Za9D3OQ8RraMdb9AluN7rAbUOuhtIES2czxE_IcQp7iPi9heEjGldXjyVf0QLtPTDVoeMvgPUWucTWqWpm18Vz3vtIrw-vmfF-svFj-XX8ur68ttycVUaTnEqWS0Zpw2vtdw0FTU1rrXuKdCq7qjkutOMMmb6ut_0AhqqqQCSnbhvhKikYWfF-YG7Df7PBDGpwUYDzukR_BQVqbiQsqlrkqXiIDXBxxigV9tgBx1mRbDadaT2HaldGYoIte9I8ex7e4yYNgN0j65_BWXB54MA8qF3FoKKxsJooLMBTFKdt_-N-PSEYI5F_oYZ4q2fwph_UREVqcIHyI5BxJ7A2QP4N7pC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1645779881</pqid></control><display><type>article</type><title>Post-Uterine Artery Embolization Pain and Clinical Outcomes for Symptomatic Myomas Using Gelfoam Pledgets Alone Versus Embospheres Plus Gelfoam Pledgets: A Comparative Pilot Study</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Vilos, Angelos G., MD ; Vilos, George A., MD ; Hollett-Caines, Jackie, MD ; Garvin, Greg, MD ; Kozak, Roman, MB BS ; Abu-Rafea, Basim, MD</creator><creatorcontrib>Vilos, Angelos G., MD ; Vilos, George A., MD ; Hollett-Caines, Jackie, MD ; Garvin, Greg, MD ; Kozak, Roman, MB BS ; Abu-Rafea, Basim, MD</creatorcontrib><description>Abstract Background To evaluate the efficacy and post-procedural pain associated with uterine artery embolization (UAE) using Gelfoam alone versus Embospheres plus Gelfoam in women with symptomatic uterine fibroids. Method We conducted a prospective, non-randomized pilot study. Fluoroscopy-guided trans-femoral artery UAE was performed using Gelfoam pledgets alone or Embospheres (500 to 700 mg) plus Gelfoam under conscious sedation and local anaesthesia. This was followed by patient-controlled analgesia (PCA) using a morphine pump overnight. Post-procedural pain was assessed by the mean amount of self-administered morphine delivered by PCA pump (mL) from 0 to 19 hours in each group. The mean volumes of the uterus and the dominant fibroid were calculated by ultrasound at baseline, three months, six months, and 12 months. Results A total of 17 women participated in the study. Bilateral uterine artery occlusion was performed in eight women using Gelfoam alone, and in nine women using Embosphere + Gelfoam. One woman in the Embosphere + Gelfoam group developed a puncture-site hematoma requiring further intervention one week later. The mean (SD) amount of morphine self-administered by PCA pump at time 0, 1, and 2 hours was 3.4 mg (3.1), 2.9 mg (2.2), and 2.4 mg (3.3) in the Gelfoam-only group and 6.1 mg (3.0), 9.6 mg (7.1), and 5.3 mg (4.4) in the Embosphere + Gelfoam group, respectively. After three hours, the amount of morphine used was equal in both groups. The mean (SD) total dose of morphine used was 29.5 mg (18.6) in the Gelfoam group and 41.1 mg (19.3) in the Embosphere + Gelfoam group ( P = 0.228). At 12 months, the reduction in median total uterine volume and median dominant fibroid volume in each group was equal. Conclusion Clinical outcomes were equivalent after uterine artery embolization using Gelfoam alone versus Gelfoam + Embospheres. Although the amount of immediate post-procedure pain may be less with Gelfoam alone, we could not demonstrate this objectively using morphine use as a measure of pain.</description><identifier>ISSN: 1701-2163</identifier><identifier>DOI: 10.1016/S1701-2163(15)30411-4</identifier><identifier>PMID: 25574675</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>abnormal uterine bleeding ; Acrylic Resins ; Adult ; Analgesia, Patient-Controlled ; Analgesics, Opioid - administration &amp; dosage ; Drug Utilization ; Embospheres ; Female ; Fibroids ; Gelatin ; Gelatin Sponge, Absorbable ; Gelfoam ; Hemostatics - therapeutic use ; Humans ; Leiomyoma - surgery ; leiomyomas ; Morphine - administration &amp; dosage ; myomas ; Obstetrics and Gynecology ; Pain, Postoperative ; Pilot Projects ; Prospective Studies ; Single-Blind Method ; uterine artery embolization ; Uterine Artery Embolization - adverse effects ; Uterine Artery Embolization - methods ; Uterine Neoplasms - surgery</subject><ispartof>Journal of obstetrics and gynaecology Canada, 2014-11, Vol.36 (11), p.983-989</ispartof><rights>Society of Obstetricians and Gynaecologists of Canada</rights><rights>2014 Society of Obstetricians and Gynaecologists of Canada</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-387342948a7b962c808aaf2e268d274ada3233cf8fbf5e92a25e14200f95567c3</citedby><cites>FETCH-LOGICAL-c420t-387342948a7b962c808aaf2e268d274ada3233cf8fbf5e92a25e14200f95567c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25574675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vilos, Angelos G., MD</creatorcontrib><creatorcontrib>Vilos, George A., MD</creatorcontrib><creatorcontrib>Hollett-Caines, Jackie, MD</creatorcontrib><creatorcontrib>Garvin, Greg, MD</creatorcontrib><creatorcontrib>Kozak, Roman, MB BS</creatorcontrib><creatorcontrib>Abu-Rafea, Basim, MD</creatorcontrib><title>Post-Uterine Artery Embolization Pain and Clinical Outcomes for Symptomatic Myomas Using Gelfoam Pledgets Alone Versus Embospheres Plus Gelfoam Pledgets: A Comparative Pilot Study</title><title>Journal of obstetrics and gynaecology Canada</title><addtitle>J Obstet Gynaecol Can</addtitle><description>Abstract Background To evaluate the efficacy and post-procedural pain associated with uterine artery embolization (UAE) using Gelfoam alone versus Embospheres plus Gelfoam in women with symptomatic uterine fibroids. Method We conducted a prospective, non-randomized pilot study. Fluoroscopy-guided trans-femoral artery UAE was performed using Gelfoam pledgets alone or Embospheres (500 to 700 mg) plus Gelfoam under conscious sedation and local anaesthesia. This was followed by patient-controlled analgesia (PCA) using a morphine pump overnight. Post-procedural pain was assessed by the mean amount of self-administered morphine delivered by PCA pump (mL) from 0 to 19 hours in each group. The mean volumes of the uterus and the dominant fibroid were calculated by ultrasound at baseline, three months, six months, and 12 months. Results A total of 17 women participated in the study. Bilateral uterine artery occlusion was performed in eight women using Gelfoam alone, and in nine women using Embosphere + Gelfoam. One woman in the Embosphere + Gelfoam group developed a puncture-site hematoma requiring further intervention one week later. The mean (SD) amount of morphine self-administered by PCA pump at time 0, 1, and 2 hours was 3.4 mg (3.1), 2.9 mg (2.2), and 2.4 mg (3.3) in the Gelfoam-only group and 6.1 mg (3.0), 9.6 mg (7.1), and 5.3 mg (4.4) in the Embosphere + Gelfoam group, respectively. After three hours, the amount of morphine used was equal in both groups. The mean (SD) total dose of morphine used was 29.5 mg (18.6) in the Gelfoam group and 41.1 mg (19.3) in the Embosphere + Gelfoam group ( P = 0.228). At 12 months, the reduction in median total uterine volume and median dominant fibroid volume in each group was equal. Conclusion Clinical outcomes were equivalent after uterine artery embolization using Gelfoam alone versus Gelfoam + Embospheres. Although the amount of immediate post-procedure pain may be less with Gelfoam alone, we could not demonstrate this objectively using morphine use as a measure of pain.</description><subject>abnormal uterine bleeding</subject><subject>Acrylic Resins</subject><subject>Adult</subject><subject>Analgesia, Patient-Controlled</subject><subject>Analgesics, Opioid - administration &amp; dosage</subject><subject>Drug Utilization</subject><subject>Embospheres</subject><subject>Female</subject><subject>Fibroids</subject><subject>Gelatin</subject><subject>Gelatin Sponge, Absorbable</subject><subject>Gelfoam</subject><subject>Hemostatics - therapeutic use</subject><subject>Humans</subject><subject>Leiomyoma - surgery</subject><subject>leiomyomas</subject><subject>Morphine - administration &amp; dosage</subject><subject>myomas</subject><subject>Obstetrics and Gynecology</subject><subject>Pain, Postoperative</subject><subject>Pilot Projects</subject><subject>Prospective Studies</subject><subject>Single-Blind Method</subject><subject>uterine artery embolization</subject><subject>Uterine Artery Embolization - adverse effects</subject><subject>Uterine Artery Embolization - methods</subject><subject>Uterine Neoplasms - surgery</subject><issn>1701-2163</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhbMA0VJ4BJCXZRHwb5ywAI1GpSAVNdIwbC2Pc1NcnHiwnUrhtfqC9fzQRTesfHV1znd0fYriDcHvCSbVhxWRmJSUVOyciHcMc0JK_qw4fVyfFC9jvMVYSCabF8UJFULySorT4r71MZXrBMGOgBYhDzO6GDbe2b86WT-iVtsR6bFDS2dHa7RD11MyfoCIeh_Qah62yQ9Za9D3OQ8RraMdb9AluN7rAbUOuhtIES2czxE_IcQp7iPi9heEjGldXjyVf0QLtPTDVoeMvgPUWucTWqWpm18Vz3vtIrw-vmfF-svFj-XX8ur68ttycVUaTnEqWS0Zpw2vtdw0FTU1rrXuKdCq7qjkutOMMmb6ut_0AhqqqQCSnbhvhKikYWfF-YG7Df7PBDGpwUYDzukR_BQVqbiQsqlrkqXiIDXBxxigV9tgBx1mRbDadaT2HaldGYoIte9I8ex7e4yYNgN0j65_BWXB54MA8qF3FoKKxsJooLMBTFKdt_-N-PSEYI5F_oYZ4q2fwph_UREVqcIHyI5BxJ7A2QP4N7pC</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Vilos, Angelos G., MD</creator><creator>Vilos, George A., MD</creator><creator>Hollett-Caines, Jackie, MD</creator><creator>Garvin, Greg, MD</creator><creator>Kozak, Roman, MB BS</creator><creator>Abu-Rafea, Basim, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141101</creationdate><title>Post-Uterine Artery Embolization Pain and Clinical Outcomes for Symptomatic Myomas Using Gelfoam Pledgets Alone Versus Embospheres Plus Gelfoam Pledgets: A Comparative Pilot Study</title><author>Vilos, Angelos G., MD ; Vilos, George A., MD ; Hollett-Caines, Jackie, MD ; Garvin, Greg, MD ; Kozak, Roman, MB BS ; Abu-Rafea, Basim, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-387342948a7b962c808aaf2e268d274ada3233cf8fbf5e92a25e14200f95567c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>abnormal uterine bleeding</topic><topic>Acrylic Resins</topic><topic>Adult</topic><topic>Analgesia, Patient-Controlled</topic><topic>Analgesics, Opioid - administration &amp; dosage</topic><topic>Drug Utilization</topic><topic>Embospheres</topic><topic>Female</topic><topic>Fibroids</topic><topic>Gelatin</topic><topic>Gelatin Sponge, Absorbable</topic><topic>Gelfoam</topic><topic>Hemostatics - therapeutic use</topic><topic>Humans</topic><topic>Leiomyoma - surgery</topic><topic>leiomyomas</topic><topic>Morphine - administration &amp; dosage</topic><topic>myomas</topic><topic>Obstetrics and Gynecology</topic><topic>Pain, Postoperative</topic><topic>Pilot Projects</topic><topic>Prospective Studies</topic><topic>Single-Blind Method</topic><topic>uterine artery embolization</topic><topic>Uterine Artery Embolization - adverse effects</topic><topic>Uterine Artery Embolization - methods</topic><topic>Uterine Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vilos, Angelos G., MD</creatorcontrib><creatorcontrib>Vilos, George A., MD</creatorcontrib><creatorcontrib>Hollett-Caines, Jackie, MD</creatorcontrib><creatorcontrib>Garvin, Greg, MD</creatorcontrib><creatorcontrib>Kozak, Roman, MB BS</creatorcontrib><creatorcontrib>Abu-Rafea, Basim, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of obstetrics and gynaecology Canada</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vilos, Angelos G., MD</au><au>Vilos, George A., MD</au><au>Hollett-Caines, Jackie, MD</au><au>Garvin, Greg, MD</au><au>Kozak, Roman, MB BS</au><au>Abu-Rafea, Basim, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Post-Uterine Artery Embolization Pain and Clinical Outcomes for Symptomatic Myomas Using Gelfoam Pledgets Alone Versus Embospheres Plus Gelfoam Pledgets: A Comparative Pilot Study</atitle><jtitle>Journal of obstetrics and gynaecology Canada</jtitle><addtitle>J Obstet Gynaecol Can</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>36</volume><issue>11</issue><spage>983</spage><epage>989</epage><pages>983-989</pages><issn>1701-2163</issn><abstract>Abstract Background To evaluate the efficacy and post-procedural pain associated with uterine artery embolization (UAE) using Gelfoam alone versus Embospheres plus Gelfoam in women with symptomatic uterine fibroids. Method We conducted a prospective, non-randomized pilot study. Fluoroscopy-guided trans-femoral artery UAE was performed using Gelfoam pledgets alone or Embospheres (500 to 700 mg) plus Gelfoam under conscious sedation and local anaesthesia. This was followed by patient-controlled analgesia (PCA) using a morphine pump overnight. Post-procedural pain was assessed by the mean amount of self-administered morphine delivered by PCA pump (mL) from 0 to 19 hours in each group. The mean volumes of the uterus and the dominant fibroid were calculated by ultrasound at baseline, three months, six months, and 12 months. Results A total of 17 women participated in the study. Bilateral uterine artery occlusion was performed in eight women using Gelfoam alone, and in nine women using Embosphere + Gelfoam. One woman in the Embosphere + Gelfoam group developed a puncture-site hematoma requiring further intervention one week later. The mean (SD) amount of morphine self-administered by PCA pump at time 0, 1, and 2 hours was 3.4 mg (3.1), 2.9 mg (2.2), and 2.4 mg (3.3) in the Gelfoam-only group and 6.1 mg (3.0), 9.6 mg (7.1), and 5.3 mg (4.4) in the Embosphere + Gelfoam group, respectively. After three hours, the amount of morphine used was equal in both groups. The mean (SD) total dose of morphine used was 29.5 mg (18.6) in the Gelfoam group and 41.1 mg (19.3) in the Embosphere + Gelfoam group ( P = 0.228). At 12 months, the reduction in median total uterine volume and median dominant fibroid volume in each group was equal. Conclusion Clinical outcomes were equivalent after uterine artery embolization using Gelfoam alone versus Gelfoam + Embospheres. Although the amount of immediate post-procedure pain may be less with Gelfoam alone, we could not demonstrate this objectively using morphine use as a measure of pain.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>25574675</pmid><doi>10.1016/S1701-2163(15)30411-4</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1701-2163
ispartof Journal of obstetrics and gynaecology Canada, 2014-11, Vol.36 (11), p.983-989
issn 1701-2163
language eng
recordid cdi_proquest_miscellaneous_1645779881
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects abnormal uterine bleeding
Acrylic Resins
Adult
Analgesia, Patient-Controlled
Analgesics, Opioid - administration & dosage
Drug Utilization
Embospheres
Female
Fibroids
Gelatin
Gelatin Sponge, Absorbable
Gelfoam
Hemostatics - therapeutic use
Humans
Leiomyoma - surgery
leiomyomas
Morphine - administration & dosage
myomas
Obstetrics and Gynecology
Pain, Postoperative
Pilot Projects
Prospective Studies
Single-Blind Method
uterine artery embolization
Uterine Artery Embolization - adverse effects
Uterine Artery Embolization - methods
Uterine Neoplasms - surgery
title Post-Uterine Artery Embolization Pain and Clinical Outcomes for Symptomatic Myomas Using Gelfoam Pledgets Alone Versus Embospheres Plus Gelfoam Pledgets: A Comparative Pilot Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T13%3A31%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Post-Uterine%20Artery%20Embolization%20Pain%20and%20Clinical%20Outcomes%20for%20Symptomatic%20Myomas%20Using%20Gelfoam%20Pledgets%20Alone%20Versus%20Embospheres%20Plus%20Gelfoam%20Pledgets:%20A%20Comparative%20Pilot%20Study&rft.jtitle=Journal%20of%20obstetrics%20and%20gynaecology%20Canada&rft.au=Vilos,%20Angelos%20G.,%20MD&rft.date=2014-11-01&rft.volume=36&rft.issue=11&rft.spage=983&rft.epage=989&rft.pages=983-989&rft.issn=1701-2163&rft_id=info:doi/10.1016/S1701-2163(15)30411-4&rft_dat=%3Cproquest_cross%3E1645779881%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1645779881&rft_id=info:pmid/25574675&rft_els_id=1_s2_0_S1701216315304114&rfr_iscdi=true